<scp>CDK8</scp> /19 inhibition triggers a switch from mitosis to endomitosis in cord blood megakaryocytes
Neonatal and adult megakaryocytes differ in proliferative capacity and ploidy levels, and neonatal and adult platelets differ in function, gene expression, and protein content. The mechanisms underlying these differences are incompletely understood. CDK8 and CDK19 are transcriptional kinases part of the CDK-mediator complex, which regulates gene transcription in a cell-specific manner. We discovered that cortistatin A, a potent highly selective inhibitor of CDK8/CDK19, significantly reduced cell expansion and increased ploidy in cord blood-derived megakaryocytes. These phenotypic changes were associated with gene expression changes that partially overlapped developmentally regulated genes. These findings might have relevance for the management of developmental megakaryocyte disorders.
Authors
- Francisca Ferrer‐Marín (ORCID: https://orcid.org/0000-0002-9520-3243)
- Lisa M. Rimsza (ORCID: https://orcid.org/0000-0003-1268-2750)
- Christopher S. Thom (ORCID: https://orcid.org/0000-0003-1830-9922)
- Matthew D. Shair (ORCID: https://orcid.org/0000-0001-9764-212X)
- Martha Sola‐Visner (ORCID: https://orcid.org/0000-0002-0013-598X)
- Henry E. Pelish (ORCID: https://orcid.org/0000-0003-2940-0326)
- Raúl Teruel‐Montoya (ORCID: https://orcid.org/0000-0002-6741-9725)
- Zhijian Liu (ORCID: https://orcid.org/0000-0003-1841-2671)
- I Niţulescu
Institutions
- Boston Children's Hospital (US)
- Salk Institute for Biological Studies (US)
- Children's Hospital of Philadelphia (US)
- Harvard University (US)
- University of Arizona (US)
- Centro Regional de Hemodonación (ES)
- Covalent Associates (United States) (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1111/bjh.19836
- Citations
- 2
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- National Heart, Lung, and Blood Institute